Search

Jehanne Souaya Sitton

Examiner (ID: 17461, Phone: (571)272-0752 , Office: P/1634 )

Most Active Art Unit
1634
Art Unit(s)
1634, 1682, 1655
Total Applications
1479
Issued Applications
528
Pending Applications
307
Abandoned Applications
653

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19226915 [patent_doc_number] => 12006549 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-11 [patent_title] => Methods utilizing leukocyte RNA expression in prognosis evaluation of medical interventions for epilepsy [patent_app_type] => utility [patent_app_number] => 17/269092 [patent_app_country] => US [patent_app_date] => 2019-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7136 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269092 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/269092
Methods utilizing leukocyte RNA expression in prognosis evaluation of medical interventions for epilepsy Oct 3, 2019 Issued
Array ( [id] => 15899191 [patent_doc_number] => 20200149114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-14 [patent_title] => DISCOVERY OF A SOMATIC MUTATION IN MYD88 GENE IN LYMPHOPLASMACYTIC LYMPHOMA [patent_app_type] => utility [patent_app_number] => 16/580523 [patent_app_country] => US [patent_app_date] => 2019-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11117 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16580523 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/580523
Discovery of a somatic mutation in MYD88 gene in lymphoplasmacytic lymphoma Sep 23, 2019 Issued
Array ( [id] => 17370418 [patent_doc_number] => 20220025470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => USE OF PROBES TO DETECT TOXIC ALGAE, DETECTION METHOD AND CORRESPONDING KITS [patent_app_type] => utility [patent_app_number] => 17/277020 [patent_app_country] => US [patent_app_date] => 2019-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54730 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17277020 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/277020
USE OF PROBES TO DETECT TOXIC ALGAE, DETECTION METHOD AND CORRESPONDING KITS Sep 16, 2019 Abandoned
Array ( [id] => 19368537 [patent_doc_number] => 12060611 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-08-13 [patent_title] => Gene expression profiles associated with sub-clinical kidney transplant rejection [patent_app_type] => utility [patent_app_number] => 16/569119 [patent_app_country] => US [patent_app_date] => 2019-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 66916 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 782 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16569119 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/569119
Gene expression profiles associated with sub-clinical kidney transplant rejection Sep 11, 2019 Issued
Array ( [id] => 16206967 [patent_doc_number] => 20200239957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-30 [patent_title] => PREDICTION AND TREATMENT OF HEART FAILURE [patent_app_type] => utility [patent_app_number] => 16/564886 [patent_app_country] => US [patent_app_date] => 2019-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26201 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16564886 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/564886
PREDICTION AND TREATMENT OF HEART FAILURE Sep 8, 2019 Abandoned
Array ( [id] => 16688774 [patent_doc_number] => 20210071250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => DIAGNOSTIC AND PROGNOSTIC LIQUID BIOPSY BIOMARKERS FOR ASTHMA [patent_app_type] => utility [patent_app_number] => 16/562861 [patent_app_country] => US [patent_app_date] => 2019-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8916 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16562861 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/562861
DIAGNOSTIC AND PROGNOSTIC LIQUID BIOPSY BIOMARKERS FOR ASTHMA Sep 5, 2019 Pending
Array ( [id] => 18779346 [patent_doc_number] => 11821041 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-21 [patent_title] => Non-invasive test to predict recurrence of colorectal cancer [patent_app_type] => utility [patent_app_number] => 16/534028 [patent_app_country] => US [patent_app_date] => 2019-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3760 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 310 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16534028 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/534028
Non-invasive test to predict recurrence of colorectal cancer Aug 6, 2019 Issued
Array ( [id] => 15832605 [patent_doc_number] => 20200131584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-30 [patent_title] => BIOMARKER DLEC1 FOR CANCER [patent_app_type] => utility [patent_app_number] => 16/530416 [patent_app_country] => US [patent_app_date] => 2019-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27032 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16530416 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/530416
Biomarker DLEC1 for cancer Aug 1, 2019 Issued
Array ( [id] => 16177308 [patent_doc_number] => 20200224276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => ncRNA AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/523008 [patent_app_country] => US [patent_app_date] => 2019-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58805 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16523008 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/523008
NcRNA and uses thereof Jul 25, 2019 Issued
Array ( [id] => 20357611 [patent_doc_number] => 12473599 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-18 [patent_title] => Gene signatures for predicting metastasis of melanoma and patient prognosis [patent_app_type] => utility [patent_app_number] => 17/262175 [patent_app_country] => US [patent_app_date] => 2019-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 17022 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17262175 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/262175
Gene signatures for predicting metastasis of melanoma and patient prognosis Jul 24, 2019 Issued
Array ( [id] => 16870589 [patent_doc_number] => 20210164056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => USE OF METASTASES-SPECIFIC SIGNATURES FOR TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 17/262471 [patent_app_country] => US [patent_app_date] => 2019-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55858 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17262471 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/262471
USE OF METASTASES-SPECIFIC SIGNATURES FOR TREATMENT OF CANCER Jul 23, 2019 Pending
Array ( [id] => 17067668 [patent_doc_number] => 20210269883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => PREDICTIVE AND PROGNOSTIC USE OF A miRNA FOR HIGH GRADE SEROUS OVARIAN CARCINOMA THERAPEUTIC CARE [patent_app_type] => utility [patent_app_number] => 17/253363 [patent_app_country] => US [patent_app_date] => 2019-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8266 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253363 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/253363
Predictive and prognostic use of a miRNA for high grade serous ovarian carcinoma therapeutic care Jul 3, 2019 Issued
Array ( [id] => 19826492 [patent_doc_number] => 12247258 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-11 [patent_title] => Epigenetic method to detect and distinguish IPEX and IPEX-like syndromes, in particular in newborns [patent_app_type] => utility [patent_app_number] => 17/255657 [patent_app_country] => US [patent_app_date] => 2019-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 4 [patent_no_of_words] => 8035 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255657 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/255657
Epigenetic method to detect and distinguish IPEX and IPEX-like syndromes, in particular in newborns Jul 2, 2019 Issued
Array ( [id] => 15963861 [patent_doc_number] => 20200165682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-28 [patent_title] => ncRNA AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/453195 [patent_app_country] => US [patent_app_date] => 2019-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29718 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16453195 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/453195
ncRNA and uses thereof Jun 25, 2019 Issued
Array ( [id] => 18636456 [patent_doc_number] => 11761044 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-19 [patent_title] => Method for evaluating whether an individual with cancer is suitable for treatment with a CDK inhibitor [patent_app_type] => utility [patent_app_number] => 16/451942 [patent_app_country] => US [patent_app_date] => 2019-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 46 [patent_no_of_words] => 11408 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16451942 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/451942
Method for evaluating whether an individual with cancer is suitable for treatment with a CDK inhibitor Jun 24, 2019 Issued
Array ( [id] => 16191190 [patent_doc_number] => 20200232039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-23 [patent_title] => ADM2 GENE MARKER FOR DIAGNOSIS OR PROGNOSIS PREDICTION OF THYROID CANCER AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/445322 [patent_app_country] => US [patent_app_date] => 2019-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5336 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16445322 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/445322
ADM2 GENE MARKER FOR DIAGNOSIS OR PROGNOSIS PREDICTION OF THYROID CANCER AND USES THEREOF Jun 18, 2019 Abandoned
Array ( [id] => 15254823 [patent_doc_number] => 20190376145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-12 [patent_title] => PREDICTION OF POOR RESPONSE TO NEOADJUVANT CHEMORADIATION IN RECTAL CANCER PATIENTS USING A DNA REPAIR SCORE [patent_app_type] => utility [patent_app_number] => 16/439027 [patent_app_country] => US [patent_app_date] => 2019-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6071 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16439027 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/439027
Prediction of poor response to neoadjuvant chemoradiation in rectal cancer patients using a DNA repair score Jun 11, 2019 Issued
Array ( [id] => 16992167 [patent_doc_number] => 20210230587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => NOVEL METHOD FOR STABILIZING NUCLEIC ACID NANOSTRUCTURES [patent_app_type] => utility [patent_app_number] => 15/734938 [patent_app_country] => US [patent_app_date] => 2019-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15838 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734938 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/734938
Method for stabilizing nucleic acid nanostructures Jun 4, 2019 Issued
Array ( [id] => 16992290 [patent_doc_number] => 20210230710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => METHODS FOR DETECTING ANTIVIRAL-DRUG RESISTANT VIRUS [patent_app_type] => utility [patent_app_number] => 15/734910 [patent_app_country] => US [patent_app_date] => 2019-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21283 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734910 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/734910
Methods for detecting antiviral-drug resistant virus Jun 3, 2019 Issued
Array ( [id] => 14808875 [patent_doc_number] => 20190271047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-05 [patent_title] => PHOSPHATIDYLINOSITOL-3-KINASE PATHWAY BIOMARKERS [patent_app_type] => utility [patent_app_number] => 16/416083 [patent_app_country] => US [patent_app_date] => 2019-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6719 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16416083 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/416083
PHOSPHATIDYLINOSITOL-3-KINASE PATHWAY BIOMARKERS May 16, 2019 Abandoned
Menu